Switch theme
Sign up to access all valuation multiples
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
2003
5.3K+
LTM Revenue $2.6B
LTM EBITDA $778M
$9.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Globus Medical has a last 12-month revenue of $2.6B and a last 12-month EBITDA of $778M.
In the most recent fiscal year, Globus Medical achieved revenue of $2.5B and an EBITDA of $474M.
Globus Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Globus Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.6B | $2.5B | XXX | XXX | XXX |
| Gross Profit | $759M | $1.0B | XXX | XXX | XXX |
| Gross Margin | 48% | 40% | XXX | XXX | XXX |
| EBITDA | $347M | $474M | XXX | XXX | XXX |
| EBITDA Margin | 22% | 19% | XXX | XXX | XXX |
| Net Profit | $190M | $123M | XXX | XXX | XXX |
| Net Margin | 12% | 5% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Globus Medical's stock price is $73.
Globus Medical has current market cap of $10.0B, and EV of $9.7B.
See Globus Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9.7B | $10.0B | XXX | XXX | XXX | XXX | $3.23 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Globus Medical has market cap of $10.0B and EV of $9.7B.
Globus Medical's trades at 3.8x LTM EV/Revenue multiple, and 12.5x LTM EBITDA.
Analysts estimate Globus Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Globus Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $9.7B | XXX | XXX | XXX |
| EV/Revenue | 3.8x | XXX | XXX | XXX |
| EV/EBITDA | 20.4x | XXX | XXX | XXX |
| P/E | 97.5x | XXX | XXX | XXX |
| P/E/Growth | 0.7x | XXX | XXX | XXX |
| EV/FCF | 23.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpGlobus Medical's NTM/LTM revenue growth is 7%
Globus Medical's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Globus Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Globus Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Globus Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 61% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 37% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 25% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 50% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Globus Medical acquired XXX companies to date.
Last acquisition by Globus Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Globus Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Globus Medical founded? | Globus Medical was founded in 2003. |
| Where is Globus Medical headquartered? | Globus Medical is headquartered in United States of America. |
| How many employees does Globus Medical have? | As of today, Globus Medical has 5.3K+ employees. |
| Who is the CEO of Globus Medical? | Globus Medical's CEO is Mr. Daniel T. Scavilla. |
| Is Globus Medical publicy listed? | Yes, Globus Medical is a public company listed on NYS. |
| What is the stock symbol of Globus Medical? | Globus Medical trades under GMED ticker. |
| When did Globus Medical go public? | Globus Medical went public in 2012. |
| Who are competitors of Globus Medical? | Similar companies to Globus Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Globus Medical? | Globus Medical's current market cap is $10.0B |
| What is the current revenue of Globus Medical? | Globus Medical's last 12-month revenue is $2.6B. |
| What is the current EBITDA of Globus Medical? | Globus Medical's last 12-month EBITDA is $778M. |
| What is the current EV/Revenue multiple of Globus Medical? | Current revenue multiple of Globus Medical is 3.8x. |
| What is the current EV/EBITDA multiple of Globus Medical? | Current EBITDA multiple of Globus Medical is 12.5x. |
| What is the current revenue growth of Globus Medical? | Globus Medical revenue growth between 2023 and 2024 was 61%. |
| Is Globus Medical profitable? | Yes, Globus Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
